Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

SER Serina Therapeutics, Inc.
$1.57 -3.09% -0.05
Notify me if price changes either direction
Interactive Brokers Logotype

Buy SER stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 16.9M
Enterprise value 16.8M
Trailing PE 1.5828402
Forward PE -0.89750695
PEG Ratio -0.004151712
Enterprise to EBITDA -0.772
Enterprise to revenue 144.964
Price to book MRQ 10.183331582373
Price to sales TTM 150.62598

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 116.0K
EBITDA -21783000
Diluted EPS TTM -1.87
Total Cash (MRQ) 8.6M
Current ratio (MRQ) 1.308
Operating Cash Flow (TTM) -16511000

SER trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent SER News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.